πŸ‡ΊπŸ‡Έ FDA
Patent

US 7871997

Cephalosporin compounds

granted A61KA61K38/00A61P

Quick answer

US patent 7871997 (Cephalosporin compounds) held by Theravance, Inc. expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61P, A61P31/04